## BAMBI GRILLEY

| | Title| Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Department of Pediatrics  
Address| 1102 BATES  
Houston, TX 77030  
  
Email|
![](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/EmailHandler.ashx?msg=Mbk57WnCOav3RYKj5X%2fX&rnd=a41998e5-298f-4bf6-b074-990448d8a178)  
ORCID ![ORCID
Icon](https://profiles.viictr.org/Framework/Images/orcid_16x16\(1\).gif)|
[0000-0003-4800-6439](http://sandbox.orcid.org/0000-0003-4800-6439)
[![Additional
info](https://profiles.viictr.org/Framework/Images/info.png)](https://profiles.viictr.org/about/default.aspx?tab=orcid)  
vCard| [Download
vCard](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/vcard.aspx?subject=266987)  
  
![](https://profiles.viictr.org/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx?NodeID=266987&cachekey=90171602-a332-4cf4-a835-94b1728959f2)  
  

Other Positions| Title| Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Center for Cell & Gene Therapy  
Division| Center for Cell & Gene Therapy  
  
  
  
  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Bibliographic  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and
other sources, which might result in incorrect or missing publications.
Faculty can
[login](https://profiles.viictr.org/loginOptions.aspx?pin=send&method=login&edit=true)
to make corrections and additions.

Newest | Oldest | Most Cited | Most Discussed | Timeline | Field Summary | Plain Text

PMC Citations indicate the number of times the publication was cited by
articles in PubMed Central, and the Altmetric score represents citations in
news articles and social media. (Note that publications are often cited in
additional ways that are not shown here.) Fields are based on how the National
Library of Medicine (NLM) classifies the publication's journal and might not
represent the specific topic of the publication. Translation tags are based on
the publication type and the MeSH terms NLM assigns to the publication. Some
publications (especially newer ones and publications not in PubMed) might not
yet be assigned Field or Translation tags.) Click a Field or Translation tag
to filter the publications.

  1. Lin FY, Stuckert A, Tat C, White M, Ruggieri L, Zhang H, Mehta B, [Lapteva N](https://profiles.viictr.org/profile/269143), [Mei Z](https://profiles.viictr.org/profile/267093), Major A, Thakkar S, Shum T, Parikh K, Wu MF, Lindsay HB, [Scherer L](https://profiles.viictr.org/profile/22016570), Shekar M, [Baxter P](https://profiles.viictr.org/profile/265524), Wang T, **Grilley B** , [Moeller K](https://profiles.viictr.org/profile/51898388), Hicks J, [Roy A](https://profiles.viictr.org/profile/268647), [Anastas J](https://profiles.viictr.org/profile/33092477), Malbari F, Aldave G, [Chintagumpala M](https://profiles.viictr.org/profile/268049), [Blaney S](https://profiles.viictr.org/profile/268174), [Parsons DW](https://profiles.viictr.org/profile/265886), [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), [Rooney CM](https://profiles.viictr.org/profile/268355), [Omer B](https://profiles.viictr.org/profile/3009902). Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors. J Clin Oncol. 2024 May 21; JCO2302019. PMID: [38771986](//www.ncbi.nlm.nih.gov/pubmed/38771986).

Citations:  Fields:

Neo Neoplasms

  2. Gardner RA, White C, Elsallab M, Farnia S, Fraint E, **Grilley B** , Bateman-House A, Grupp SA, Kenderian S, Locke FL, Nikiforow S, Oluwole OO, [Rouce RH](https://profiles.viictr.org/profile/3010108), Spiegel J, Shah NN, Sharma A, Komanduri K, Gill S. ACT To Sustain: Adoptive Cell Therapy To Sustain Access to Non-Commercialized Genetically Modified Cell Therapies. Transplant Cell Ther. 2024 May 16. PMID: [38762057](//www.ncbi.nlm.nih.gov/pubmed/38762057).

Citations:  Fields:

Hem HematologyTra Transplantation

  3. [Hegde M](https://profiles.viictr.org/profile/270076), [Navai S](https://profiles.viictr.org/profile/6714386), DeRenzo C, [Joseph SK](https://profiles.viictr.org/profile/31879883), Sanber K, Wu M, [Gad AZ](https://profiles.viictr.org/profile/24845005), Janeway KA, Campbell M, [Mullikin D](https://profiles.viictr.org/profile/17411489), Nawas Z, Robertson C, Mathew PR, Zhang H, Mehta B, Bhat RR, Major A, Shree A, Gerken C, Kalra M, Chakraborty R, Thakkar SG, Dakhova O, Salsman VS, **Grilley B** , [Lapteva N](https://profiles.viictr.org/profile/269143), [Gee A](https://profiles.viictr.org/profile/268378), Dotti G, Bao R, Salem AH, Wang T, [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), Wels WS, Hicks MJ, [Gottschalk S](https://profiles.viictr.org/profile/270181), [Ahmed N](https://profiles.viictr.org/profile/268944). Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial. Nat Cancer. 2024 Jun; 5(6):880-894. PMID: [38658775](//www.ncbi.nlm.nih.gov/pubmed/38658775).

Citations:  Fields:

Neo Neoplasms

Translation:HumansCellsCTClinical Trials

  4. Che-Hsing L, Sharma S, [Heczey AA](https://profiles.viictr.org/profile/268789), [Steffin DHM](https://profiles.viictr.org/profile/14348352), Louis CU, **Grilley BJ** , Thakkar SG, Wu M, Wang T, [Rooney CM](https://profiles.viictr.org/profile/268355), [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811). Eighteen-year survival after GD2-directed Chimeric Antigen Receptor-Modified Immune Effector Cell Treatment for Neuroblastoma. Res Sq. 2024 Apr 11. PMID: [38659815](//www.ncbi.nlm.nih.gov/pubmed/38659815); PMCID: [PMC11042400](//www.ncbi.nlm.nih.gov/pmc/articles/PMC11042400).

Citations:

  5. [Steffin D](https://profiles.viictr.org/profile/14348352), Ghatwai N, Montalbano A, Rathi P, [Courtney AN](https://profiles.viictr.org/profile/9596407), [Arnett AB](https://profiles.viictr.org/profile/34774547), Fleurence J, Sweidan R, Wang T, Zhang H, [Masand P](https://profiles.viictr.org/profile/269955), Maris JM, Martinez D, Pogoriler J, Varadarajan N, Thakkar SG, Lyon D, Lapteva N, [Mei Z](https://profiles.viictr.org/profile/267093), Patel K, [Lopez-Terrada D](https://profiles.viictr.org/profile/266283), [Ramos C](https://profiles.viictr.org/profile/267038), [Lulla P](https://profiles.viictr.org/profile/3010220), [Armaghany T](https://profiles.viictr.org/profile/28999477), **Grilley BJ** , Dotti G, [Metelitsa LS](https://profiles.viictr.org/profile/266187), [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), [Sumazin P](https://profiles.viictr.org/profile/2560346), [Heczey A](https://profiles.viictr.org/profile/268789). Interleukin-15-armored GPC3-CAR T cells for patients with solid cancers. Res Sq. 2024 Apr 03. PMID: [38645165](//www.ncbi.nlm.nih.gov/pubmed/38645165); PMCID: [PMC11030543](//www.ncbi.nlm.nih.gov/pmc/articles/PMC11030543).

Citations:

  6. [Heczey A](https://profiles.viictr.org/profile/268789), Xu X, [Courtney AN](https://profiles.viictr.org/profile/9596407), [Tian G](https://profiles.viictr.org/profile/1826488), Barragan GA, Guo L, Amador CM, Ghatwai N, Rathi P, Wood MS, Li Y, Zhang C, Demberg T, Di Pierro EJ, [Sher AC](https://profiles.viictr.org/profile/14348256), Zhang H, Mehta B, Thakkar SG, **Grilley B** , Wang T, Weiss BD, Montalbano A, Subramaniam M, Xu C, Sachar C, Wells DK, Dotti G, [Metelitsa LS](https://profiles.viictr.org/profile/266187). Author Correction: Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results. Nat Med. 2024 Apr; 30(4):1210. PMID: [38195754](//www.ncbi.nlm.nih.gov/pubmed/38195754).

Citations:  Fields:

Med Medicine (General)Mol Molecular Biology

  7. [Musher BL](https://profiles.viictr.org/profile/266798), Rowinsky EK, Smaglo BG, [Abidi W](https://profiles.viictr.org/profile/21983660), [Othman M](https://profiles.viictr.org/profile/8759795), Patel K, [Jawaid S](https://profiles.viictr.org/profile/30086495), Jing J, Brisco A, [Leen AM](https://profiles.viictr.org/profile/268626), Wu M, Sandin LC, Wenthe J, Eriksson E, Ullenhag GJ, **Grilley B** , Leja-Jarblad J, [Hilsenbeck SG](https://profiles.viictr.org/profile/268374), [Brenner MK](https://profiles.viictr.org/profile/268200), Loskog ASI. LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study. Lancet Oncol. 2024 Apr; 25(4):488-500. PMID: [38547893](//www.ncbi.nlm.nih.gov/pubmed/38547893).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/38547893/citedby/) Fields:

Neo Neoplasms

Translation:HumansCellsCTClinical Trials

  8. Hill LC, [Rouce RH](https://profiles.viictr.org/profile/3010108), Wu MJ, Wang T, Ma R, Zhang H, Mehta B, [Lapteva N](https://profiles.viictr.org/profile/269143), [Mei Z](https://profiles.viictr.org/profile/267093), Smith TS, Yang L, Srinivasan M, [Burkhardt PM](https://profiles.viictr.org/profile/31454204), [Ramos CA](https://profiles.viictr.org/profile/267038), [Lulla P](https://profiles.viictr.org/profile/3010220), Arredondo M, **Grilley B** , [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), [Mamonkin M](https://profiles.viictr.org/profile/1826306). Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas. Blood. 2024 Mar 28; 143(13):1231-1241. PMID: [38145560](//www.ncbi.nlm.nih.gov/pubmed/38145560); PMCID: [PMC10997912](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10997912).

Citations:  Fields:

Hem Hematology

Translation:HumansCells

  9. Kapadia CD, Rosas G, Thakkar SG, Wu M, Torrano V, Wang T, **Grilley BJ** , [Heslop HE](https://profiles.viictr.org/profile/269811), [Ramos CA](https://profiles.viictr.org/profile/267038), [Goodell MA](https://profiles.viictr.org/profile/269806), [Lulla PD](https://profiles.viictr.org/profile/3010220). Incipient clonal hematopoiesis is accelerated following CD30.CAR-T therapy. Cytotherapy. 2024 03; 26(3):261-265. PMID: [38149948](//www.ncbi.nlm.nih.gov/pubmed/38149948); PMCID: [PMC10922117](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10922117).

Citations:  Fields:

Cel Cell BiologyThe Therapeutics

Translation:Humans

  10. Ikonomou L, Cuende N, Forte M, **Grilley BJ** , Levine AD, Munsie M, Rasko JEJ, Turner L, Bidkhori HR, Ciccocioppo R, Grignon F, Srivastava A, Weiss DJ, Zettler P, Levine BL, ISCT Committee on the Ethics of Cell and Gene Therapy (ECGT). International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products. Cytotherapy. 2023 09; 25(9):920-929. PMID: [37517865](//www.ncbi.nlm.nih.gov/pubmed/37517865).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/37517865/citedby/) Fields:

Cel Cell BiologyThe Therapeutics

Translation:Humans

  11. [Vasileiou S](https://profiles.viictr.org/profile/22016531), Hill L, Kuvalekar M, Workineh AG, Watanabe A, Velazquez Y, [Lulla S](https://profiles.viictr.org/profile/34811365), Mooney K, [Lapteva N](https://profiles.viictr.org/profile/269143), **Grilley BJ** , [Heslop HE](https://profiles.viictr.org/profile/269811), [Rooney CM](https://profiles.viictr.org/profile/268355), [Brenner MK](https://profiles.viictr.org/profile/268200), Eagar TN, [Carrum G](https://profiles.viictr.org/profile/269657), Grimes KA, [Leen AM](https://profiles.viictr.org/profile/268626), [Lulla P](https://profiles.viictr.org/profile/3010220). Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients. Haematologica. 2023 Jul 01; 108(7):1840-1850. PMID: [36373249](//www.ncbi.nlm.nih.gov/pubmed/36373249); PMCID: [PMC10316279](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10316279).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/36373249/citedby/) Fields:

Hem Hematology

Translation:HumansCellsCTClinical Trials

  12. [Heczey A](https://profiles.viictr.org/profile/268789), [Xu X](https://profiles.viictr.org/profile/12328491), [Courtney AN](https://profiles.viictr.org/profile/9596407), [Tian G](https://profiles.viictr.org/profile/1826488), Barragan GA, Guo L, Amador CM, Ghatwai N, Rathi P, Wood MS, Li Y, Zhang C, Demberg T, Di Pierro EJ, [Sher AC](https://profiles.viictr.org/profile/14348256), Zhang H, Mehta B, Thakkar SG, **Grilley B** , Wang T, Weiss BD, Montalbano A, Subramaniam M, Xu C, Sachar C, Wells DK, Dotti G, [Metelitsa LS](https://profiles.viictr.org/profile/266187). Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results. Nat Med. 2023 Jun; 29(6):1379-1388. PMID: [37188782](//www.ncbi.nlm.nih.gov/pubmed/37188782).

Citations:
[17](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/37188782/citedby/) Fields:

Med Medicine (General)Mol Molecular Biology

Translation:HumansAnimalsCellsCTClinical Trials

  13. Zettler PJ, Ikonomou L, Levine AD, Turner L, **Grilley B** , Roxland BE. An International Society for Cell & Gene Therapy working group short report on the future of expanded access to unapproved cell and gene therapies. Cytotherapy. 2023 07; 25(7):712-717. PMID: [37097267](//www.ncbi.nlm.nih.gov/pubmed/37097267).

Citations:  Fields:

Cel Cell BiologyThe Therapeutics

Translation:Humans

  14. Wang D, Porter CE, Lim B, [Rosewell Shaw A](https://profiles.viictr.org/profile/1826695), Robertson CS, [Woods ML](https://profiles.viictr.org/profile/31330385), Xu Y, Biegert GGW, Morita D, Wang T, **Grilley BJ** , [Heslop H](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), [Suzuki M](https://profiles.viictr.org/profile/265870). Ultralow-dose binary oncolytic/helper-dependent adenovirus promotes antitumor activity in preclinical and clinical studies. Sci Adv. 2023 03 29; 9(13):eade6790. PMID: [36989357](//www.ncbi.nlm.nih.gov/pubmed/36989357); PMCID: [PMC10058234](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10058234).

Citations:  Fields:

Sci Science

Translation:AnimalsCells

  15. Cornetta K, Yao J, House K, Duffy L, Adusumilli PS, Beyer R, Booth C, [Brenner M](https://profiles.viictr.org/profile/268200), Curran K, **Grilley B** , [Heslop H](https://profiles.viictr.org/profile/269811), Hinrichs CS, Kaplan RN, Kiem HP, Kochenderfer J, Kohn DB, Mailankody S, Norberg SM, O'Cearbhaill RE, Pappas J, Park J, [Ramos C](https://profiles.viictr.org/profile/267038), Ribas A, Rivi?re I, Rosenberg SA, Sauter C, Shah NN, Slovin SF, Thrasher A, Williams DA, Lin TY. Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials. Mol Ther. 2023 03 01; 31(3):801-809. PMID: [36518078](//www.ncbi.nlm.nih.gov/pubmed/36518078); PMCID: [PMC10014217](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10014217).

Citations:  Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansCells

  16. [Hoyos V](https://profiles.viictr.org/profile/23479202), [Vasileiou S](https://profiles.viictr.org/profile/22016531), Kuvalekar M, Watanabe A, Tzannou I, Velazquez Y, French-Kim M, Leung W, [Lulla S](https://profiles.viictr.org/profile/34811365), Robertson C, Foreman C, Wang T, Bulsara S, [Lapteva N](https://profiles.viictr.org/profile/269143), **Grilley B** , Ellis M, Osborne CK, Coscio A, [Nangia J](https://profiles.viictr.org/profile/266130), [Heslop HE](https://profiles.viictr.org/profile/269811), [Rooney CM](https://profiles.viictr.org/profile/268355), Vera JF, [Lulla P](https://profiles.viictr.org/profile/3010220), [Rimawi M](https://profiles.viictr.org/profile/269416), [Leen AM](https://profiles.viictr.org/profile/268626). Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancer. Ther Adv Med Oncol. 2022; 14:17588359221107113. PMID: [35860837](//www.ncbi.nlm.nih.gov/pubmed/35860837); PMCID: [PMC9290161](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9290161).

Citations:

  17. [Steffin DHM](https://profiles.viictr.org/profile/14348352), Muhsen IN, Hill LC, [Ramos CA](https://profiles.viictr.org/profile/267038), [Ahmed N](https://profiles.viictr.org/profile/268944), [Hegde M](https://profiles.viictr.org/profile/270076), Wang T, Wu M, [Gottschalk S](https://profiles.viictr.org/profile/270181), [Whittle SB](https://profiles.viictr.org/profile/3009971), [Lulla PD](https://profiles.viictr.org/profile/3010220), [Mamonkin M](https://profiles.viictr.org/profile/1826306), [Omer B](https://profiles.viictr.org/profile/3009902), [Rouce RH](https://profiles.viictr.org/profile/3010108), [Heczey A](https://profiles.viictr.org/profile/268789), [Metelitsa LS](https://profiles.viictr.org/profile/266187), **Grilley BJ** , Robertson C, Torrano V, [Lapteva N](https://profiles.viictr.org/profile/269143), [Gee AP](https://profiles.viictr.org/profile/268378), [Rooney CM](https://profiles.viictr.org/profile/268355), [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811). Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs. Blood. 2022 07 07; 140(1):16-24. PMID: [35325065](//www.ncbi.nlm.nih.gov/pubmed/35325065); PMCID: [PMC9346960](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9346960).

Citations:  Fields:

Hem Hematology

Translation:HumansCells

  18. Naik S, [Vasileiou S](https://profiles.viictr.org/profile/22016531), Tzannou I, Kuvalekar M, Watanabe A, Robertson C, [Lapteva N](https://profiles.viictr.org/profile/269143), Tao W, Wu M, **Grilley B** , [Carrum G](https://profiles.viictr.org/profile/269657), [Kamble RT](https://profiles.viictr.org/profile/265557), Hill L, [Krance RA](https://profiles.viictr.org/profile/268199), [Martinez C](https://profiles.viictr.org/profile/265827), Tewari P, [Omer B](https://profiles.viictr.org/profile/3009902), [Gottschalk S](https://profiles.viictr.org/profile/270181), [Heslop HE](https://profiles.viictr.org/profile/269811), Brenner MK, [Rooney CM](https://profiles.viictr.org/profile/268355), Vera JF, [Leen AM](https://profiles.viictr.org/profile/268626), [Lulla PD](https://profiles.viictr.org/profile/3010220). Donor-derived multiple leukemia antigen-specific T-cell therapy to prevent relapse after transplant?in patients with ALL. Blood. 2022 04 28; 139(17):2706-2711. PMID: [35134127](//www.ncbi.nlm.nih.gov/pubmed/35134127); PMCID: [PMC9053698](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9053698).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/35134127/citedby/) Fields:

Hem Hematology

Translation:Humans

  19. **GRILLEY B** J. Drug Information: A Guide for Pharmacists (McGraw-Hill). Investigational Drugs in the Principles and Practice of Drug Information. 2022; 1013-1057.

  20. **GRILLEY B** J. Cell Therapy: cGMP Facilities and Manufacturing (Springer). IND Applications for Cellular Therapy Products. 2022; 119-143.

  21. **GRILLEY B** J. FDA and Drug Development. 2022. [View Publication](https://stbaldricks.talentlms.com).

  22. **GRILLEY B** J. How a Clinical Trial is Opened at an Institution. 2022. [View Publication](https://stbaldricks.talentlms.com).

  23. **GRILLEY B** J. Ethics in the Treatment of Pediatric Cancer Patients. 2022. [View Publication](https://stbaldricks.talentlms.com).

  24. **GRILLEY B** J. The Patient Advocate Role in Scientific Review. 2022. [View Publication](https://stbaldricks.talentlms.com).

  25. [Lulla PD](https://profiles.viictr.org/profile/3010220), Naik S, [Vasileiou S](https://profiles.viictr.org/profile/22016531), Tzannou I, Watanabe A, Kuvalekar M, [Lulla S](https://profiles.viictr.org/profile/34811365), [Carrum G](https://profiles.viictr.org/profile/269657), [Ramos CA](https://profiles.viictr.org/profile/267038), [Kamble R](https://profiles.viictr.org/profile/265557), Hill L, Randhawa J, [Gottschalk S](https://profiles.viictr.org/profile/270181), [Krance R](https://profiles.viictr.org/profile/268199), Wang T, Wu M, Robertson C, [Gee AP](https://profiles.viictr.org/profile/268378), Chung B, **Grilley B** , [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), Vera JF, [Leen AM](https://profiles.viictr.org/profile/268626). Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant. Blood. 2021 05 13; 137(19):2585-2597. PMID: [33270816](//www.ncbi.nlm.nih.gov/pubmed/33270816); PMCID: [PMC8120140](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8120140).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33270816/citedby/) Fields:

Hem Hematology

Translation:HumansCellsCTClinical Trials

  26. [Vasileiou S](https://profiles.viictr.org/profile/22016531), [Lulla PD](https://profiles.viictr.org/profile/3010220), Tzannou I, Watanabe A, Kuvalekar M, Callejas WL, Bilgi M, Wang T, Wu MJ, [Kamble R](https://profiles.viictr.org/profile/265557), [Ramos CA](https://profiles.viictr.org/profile/267038), [Rouce RH](https://profiles.viictr.org/profile/3010108), Zeng Z, [Gee AP](https://profiles.viictr.org/profile/268378), **Grilley BJ** , Vera JF, Bollard CM, [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), [Rooney CM](https://profiles.viictr.org/profile/268355), [Leen AM](https://profiles.viictr.org/profile/268626), [Carrum G](https://profiles.viictr.org/profile/269657). T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects. J Clin Oncol. 2021 05 01; 39(13):1415-1425. PMID: [33507803](//www.ncbi.nlm.nih.gov/pubmed/33507803); PMCID: [PMC8274795](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8274795).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33507803/citedby/) Fields:

Neo Neoplasms

Translation:HumansCellsCTClinical Trials

  27. [Lulla PD](https://profiles.viictr.org/profile/3010220), Tzannou I, [Vasileiou S](https://profiles.viictr.org/profile/22016531), [Carrum G](https://profiles.viictr.org/profile/269657), [Ramos CA](https://profiles.viictr.org/profile/267038), [Kamble R](https://profiles.viictr.org/profile/265557), Wang T, Wu M, Bilgi M, [Gee AP](https://profiles.viictr.org/profile/268378), Mukhi S, Chung B, Wang L, Watanabe A, Kuvalekar M, [Jeong M](https://profiles.viictr.org/profile/3010235), Li Y, [Ketkar S](https://profiles.viictr.org/profile/28999445), French-Kim M, **Grilley B** , [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), Vera JF, [Leen AM](https://profiles.viictr.org/profile/268626). The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myeloma. Sci Transl Med. 2020 07 29; 12(554). PMID: [32727914](//www.ncbi.nlm.nih.gov/pubmed/32727914).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32727914/citedby/) Fields:

Med Medicine (General)Sci Science

Translation:Humans

  28. [Ramos CA](https://profiles.viictr.org/profile/267038), Grover NS, Beaven AW, [Lulla PD](https://profiles.viictr.org/profile/3010220), Wu MF, Ivanova A, Wang T, Shea TC, [Rooney CM](https://profiles.viictr.org/profile/268355), Dittus C, Park SI, [Gee AP](https://profiles.viictr.org/profile/268378), Eldridge PW, McKay KL, Mehta B, Cheng CJ, Buchanan FB, **Grilley BJ** , Morrison K, [Brenner MK](https://profiles.viictr.org/profile/268200), Serody JS, Dotti G, [Heslop HE](https://profiles.viictr.org/profile/269811), Savoldo B. Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma. J Clin Oncol. 2020 11 10; 38(32):3794-3804. PMID: [32701411](//www.ncbi.nlm.nih.gov/pubmed/32701411); PMCID: [PMC7655020](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7655020).

Citations:
[57](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32701411/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  29. [Hegde M](https://profiles.viictr.org/profile/270076), [Joseph SK](https://profiles.viictr.org/profile/31879883), Pashankar F, DeRenzo C, Sanber K, [Navai S](https://profiles.viictr.org/profile/6714386), Byrd TT, Hicks J, Xu ML, Gerken C, Kalra M, Robertson C, Zhang H, Shree A, Mehta B, Dakhova O, Salsman VS, **Grilley B** , [Gee A](https://profiles.viictr.org/profile/268378), Dotti G, [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), Wels WS, [Gottschalk S](https://profiles.viictr.org/profile/270181), [Ahmed N](https://profiles.viictr.org/profile/268944). Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma. Nat Commun. 2020 07 15; 11(1):3549. PMID: [32669548](//www.ncbi.nlm.nih.gov/pubmed/32669548); PMCID: [PMC7363864](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7363864).

Citations:
[33](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32669548/citedby/) Fields:

Bio BiologySci Science

Translation:HumansCells

  30. Abraham AA, John TD, Keller MD, Cruz CRN, [Salem B](https://profiles.viictr.org/profile/29494168), Roesch L, Liu H, Hoq F, **Grilley BJ** , [Gee AP](https://profiles.viictr.org/profile/268378), Dave H, Jacobsohn DA, [Krance RA](https://profiles.viictr.org/profile/268199), [Shpall EJ](https://profiles.viictr.org/profile/12582631), [Martinez CA](https://profiles.viictr.org/profile/265827), Hanley PJ, Bollard CM. Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients. Blood Adv. 2019 07 23; 3(14):2057-2068. PMID: [31292125](//www.ncbi.nlm.nih.gov/pubmed/31292125); PMCID: [PMC6650740](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6650740).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31292125/citedby/) Fields:

Hem Hematology

  31. McLaughlin LP, [Rouce R](https://profiles.viictr.org/profile/3010108), [Gottschalk S](https://profiles.viictr.org/profile/270181), Torrano V, [Carrum G](https://profiles.viictr.org/profile/269657), Wu MF, Hoq F, **Grilley B** , Marcogliese AM, Hanley PJ, [Gee AP](https://profiles.viictr.org/profile/268378), [Brenner MK](https://profiles.viictr.org/profile/268200), [Rooney CM](https://profiles.viictr.org/profile/268355), [Heslop HE](https://profiles.viictr.org/profile/269811), Bollard CM. EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation. Blood. 2018 11 29; 132(22):2351-2361. PMID: [30262660](//www.ncbi.nlm.nih.gov/pubmed/30262660); PMCID: [PMC6265652](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6265652).

Citations:
[18](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30262660/citedby/) Fields:

Hem Hematology

Translation:HumansCellsCTClinical Trials

  32. [Ramos CA](https://profiles.viictr.org/profile/267038), [Rouce R](https://profiles.viictr.org/profile/3010108), Robertson CS, Reyna A, Narala N, Vyas G, Mehta B, Zhang H, Dakhova O, [Carrum G](https://profiles.viictr.org/profile/269657), [Kamble RT](https://profiles.viictr.org/profile/265557), [Gee AP](https://profiles.viictr.org/profile/268378), [Mei Z](https://profiles.viictr.org/profile/267093), Wu MF, Liu H, **Grilley B** , [Rooney CM](https://profiles.viictr.org/profile/268355), [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), Savoldo B, Dotti G. In?Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin's Lymphomas. Mol Ther. 2018 12 05; 26(12):2727-2737. PMID: [30309819](//www.ncbi.nlm.nih.gov/pubmed/30309819); PMCID: [PMC6277484](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6277484).

Citations:
[77](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30309819/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansCells

  33. [Ramos CA](https://profiles.viictr.org/profile/267038), Ballard B, Zhang H, Dakhova O, [Gee AP](https://profiles.viictr.org/profile/268378), [Mei Z](https://profiles.viictr.org/profile/267093), Bilgi M, Wu MF, Liu H, **Grilley B** , Bollard CM, Chang BH, [Rooney CM](https://profiles.viictr.org/profile/268355), [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), Dotti G, Savoldo B. Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes. J Clin Invest. 2017 Sep 01; 127(9):3462-3471. PMID: [28805662](//www.ncbi.nlm.nih.gov/pubmed/28805662); PMCID: [PMC5669573](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5669573).

Citations:
[140](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28805662/citedby/)
Fields:

Med Medicine (General)

Translation:HumansCellsCTClinical Trials

  34. Tzannou I, Papadopoulou A, Naik S, Leung K, [Martinez CA](https://profiles.viictr.org/profile/265827), [Ramos CA](https://profiles.viictr.org/profile/267038), [Carrum G](https://profiles.viictr.org/profile/269657), Sasa G, [Lulla P](https://profiles.viictr.org/profile/3010220), Watanabe A, Kuvalekar M, [Gee AP](https://profiles.viictr.org/profile/268378), Wu MF, Liu H, **Grilley BJ** , [Krance RA](https://profiles.viictr.org/profile/268199), [Gottschalk S](https://profiles.viictr.org/profile/270181), [Brenner MK](https://profiles.viictr.org/profile/268200), [Rooney CM](https://profiles.viictr.org/profile/268355), [Heslop HE](https://profiles.viictr.org/profile/269811), [Leen AM](https://profiles.viictr.org/profile/268626), [Omer B](https://profiles.viictr.org/profile/3009902). Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation. J Clin Oncol. 2017 Nov 01; 35(31):3547-3557. PMID: [28783452](//www.ncbi.nlm.nih.gov/pubmed/28783452); PMCID: [PMC5662844](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5662844).

Citations:
[135](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28783452/citedby/)
Fields:

Neo Neoplasms

Translation:HumansCellsCTClinical Trials

  35. [Ahmed N](https://profiles.viictr.org/profile/268944), Brawley V, [Hegde M](https://profiles.viictr.org/profile/270076), Bielamowicz K, Kalra M, Landi D, Robertson C, Gray TL, Diouf O, Wakefield A, Ghazi A, Gerken C, Yi Z, Ashoori A, Wu MF, Liu H, [Rooney C](https://profiles.viictr.org/profile/268355), Dotti G, [Gee A](https://profiles.viictr.org/profile/268378), [Su J](https://profiles.viictr.org/profile/268196), Kew Y, Baskin D, Zhang YJ, New P, **Grilley B** , Stojakovic M, Hicks J, [Powell SZ](https://profiles.viictr.org/profile/269823), [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), Grossman R, Wels WS, [Gottschalk S](https://profiles.viictr.org/profile/270181). HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial. JAMA Oncol. 2017 Aug 01; 3(8):1094-1101. PMID: [28426845](//www.ncbi.nlm.nih.gov/pubmed/28426845); PMCID: [PMC5747970](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5747970).

Citations:
[269](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28426845/citedby/)
Fields:

Neo Neoplasms

Translation:HumansCellsCTClinical Trials

  36. [Heczey A](https://profiles.viictr.org/profile/268789), Louis CU, Savoldo B, Dakhova O, Durett A, **Grilley B** , Liu H, Wu MF, [Mei Z](https://profiles.viictr.org/profile/267093), [Gee A](https://profiles.viictr.org/profile/268378), Mehta B, Zhang H, [Mahmood N](https://profiles.viictr.org/profile/269285), Tashiro H, [Heslop HE](https://profiles.viictr.org/profile/269811), Dotti G, [Rooney CM](https://profiles.viictr.org/profile/268355), [Brenner MK](https://profiles.viictr.org/profile/268200). CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma. Mol Ther. 2017 09 06; 25(9):2214-2224. PMID: [28602436](//www.ncbi.nlm.nih.gov/pubmed/28602436); PMCID: [PMC5589058](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5589058).

Citations:
[168](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28602436/citedby/)
Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansCells

  37. **GRILLEY B** J. Drug Information: A Guide for Pharmacists (McGraw-Hill). Investigational Drugs in the Principles and Practice of Drug Information. 2017; 933-975.

  38. [Ramos CA](https://profiles.viictr.org/profile/267038), Savoldo B, Torrano V, Ballard B, Zhang H, Dakhova O, Liu E, [Carrum G](https://profiles.viictr.org/profile/269657), [Kamble RT](https://profiles.viictr.org/profile/265557), [Gee AP](https://profiles.viictr.org/profile/268378), [Mei Z](https://profiles.viictr.org/profile/267093), Wu MF, Liu H, **Grilley B** , [Rooney CM](https://profiles.viictr.org/profile/268355), [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), Dotti G. Clinical responses with T lymphocytes targeting malignancy-associated ? light chains. J Clin Invest. 2016 07 01; 126(7):2588-96. PMID: [27270177](//www.ncbi.nlm.nih.gov/pubmed/27270177); PMCID: [PMC4922690](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4922690).

Citations:
[131](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27270177/citedby/)
Fields:

Med Medicine (General)

Translation:HumansCellsCTClinical Trials

  39. **Grilley BJ**. Ethical Considerations in Pediatric Stem Cell Donation. Biol Blood Marrow Transplant. 2016 Jan; 22(1):3. PMID: [26585503](//www.ncbi.nlm.nih.gov/pubmed/26585503).

Citations:  Fields:

Hem HematologyTra Transplantation

Translation:HumansCells

  40. Zhou X, Dotti G, [Krance RA](https://profiles.viictr.org/profile/268199), [Martinez CA](https://profiles.viictr.org/profile/265827), Naik S, [Kamble RT](https://profiles.viictr.org/profile/265557), Durett AG, Dakhova O, Savoldo B, Di Stasi A, Spencer DM, Lin YF, [Liu H](https://profiles.viictr.org/profile/265543), **Grilley BJ** , [Gee AP](https://profiles.viictr.org/profile/268378), [Rooney CM](https://profiles.viictr.org/profile/268355), [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200). Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation. Blood. 2015 Jun 25; 125(26):4103-13. PMID: [25977584](//www.ncbi.nlm.nih.gov/pubmed/25977584); PMCID: [PMC4481597](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4481597).

Citations:
[97](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25977584/citedby/) Fields:

Hem Hematology

Translation:HumansCellsCTClinical Trials

  41. [Ahmed N](https://profiles.viictr.org/profile/268944), Brawley VS, [Hegde M](https://profiles.viictr.org/profile/270076), Robertson C, Ghazi A, Gerken C, Liu E, Dakhova O, Ashoori A, Corder A, Gray T, Wu MF, [Liu H](https://profiles.viictr.org/profile/265543), Hicks J, [Rainusso N](https://profiles.viictr.org/profile/265526), Dotti G, [Mei Z](https://profiles.viictr.org/profile/267093), **Grilley B** , [Gee A](https://profiles.viictr.org/profile/268378), [Rooney CM](https://profiles.viictr.org/profile/268355), [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), Wels WS, [Wang LL](https://profiles.viictr.org/profile/267005), Anderson P, [Gottschalk S](https://profiles.viictr.org/profile/270181). Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma. J Clin Oncol. 2015 May 20; 33(15):1688-96. PMID: [25800760](//www.ncbi.nlm.nih.gov/pubmed/25800760); PMCID: [PMC4429176](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4429176).

Citations:
[373](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25800760/citedby/)
Fields:

Neo Neoplasms

Translation:HumansCellsCTClinical Trials

  42. Zhou X, Di Stasi A, Tey SK, [Krance RA](https://profiles.viictr.org/profile/268199), [Martinez C](https://profiles.viictr.org/profile/265827), Leung KS, Durett AG, Wu MF, [Liu H](https://profiles.viictr.org/profile/265543), [Leen AM](https://profiles.viictr.org/profile/268626), Savoldo B, Lin YF, **Grilley BJ** , [Gee AP](https://profiles.viictr.org/profile/268378), Spencer DM, [Rooney CM](https://profiles.viictr.org/profile/268355), [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), Dotti G. Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene. Blood. 2014 Jun 19; 123(25):3895-905. PMID: [24753538](//www.ncbi.nlm.nih.gov/pubmed/24753538); PMCID: [PMC4064331](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4064331).

Citations:
[86](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24753538/citedby/) Fields:

Hem Hematology

Translation:HumansAnimalsCellsCTClinical Trials

  43. **GRILLEY B** J. Drug Information: A Guide for Pharmacists. Investigational Drugs in the Principles and Practice of Drug Information. 2014.

  44. **GRILLEY B** J. Cancer Gene Therapy by Viral and Non-viral Vectors. Regulations Governing Clinical Trials in Gene Therapy. 2014.

  45. Cruz CR, Micklethwaite KP, Savoldo B, [Ramos CA](https://profiles.viictr.org/profile/267038), Lam S, Ku S, Diouf O, Liu E, Barrett AJ, Ito S, [Shpall EJ](https://profiles.viictr.org/profile/12582631), [Krance RA](https://profiles.viictr.org/profile/268199), [Kamble RT](https://profiles.viictr.org/profile/265557), [Carrum G](https://profiles.viictr.org/profile/269657), [Hosing CM](https://profiles.viictr.org/profile/12583741), [Gee AP](https://profiles.viictr.org/profile/268378), [Mei Z](https://profiles.viictr.org/profile/267093), **Grilley BJ** , [Heslop HE](https://profiles.viictr.org/profile/269811), [Rooney CM](https://profiles.viictr.org/profile/268355), [Brenner MK](https://profiles.viictr.org/profile/268200), Bollard CM, Dotti G. Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study. Blood. 2013 Oct 24; 122(17):2965-73. PMID: [24030379](//www.ncbi.nlm.nih.gov/pubmed/24030379); PMCID: [PMC3811171](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3811171).

Citations:
[231](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24030379/citedby/)
Fields:

Hem Hematology

Translation:HumansCellsCTClinical Trials

  46. [Leen AM](https://profiles.viictr.org/profile/268626), Bollard CM, Mendizabal AM, [Shpall EJ](https://profiles.viictr.org/profile/12582631), Szabolcs P, Antin JH, Kapoor N, Pai SY, Rowley SD, [Kebriaei P](https://profiles.viictr.org/profile/12582909), Dey BR, **Grilley BJ** , [Gee AP](https://profiles.viictr.org/profile/268378), [Brenner MK](https://profiles.viictr.org/profile/268200), [Rooney CM](https://profiles.viictr.org/profile/268355), [Heslop HE](https://profiles.viictr.org/profile/269811). Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation. Blood. 2013 Jun 27; 121(26):5113-23. PMID: [23610374](//www.ncbi.nlm.nih.gov/pubmed/23610374); PMCID: [PMC3695359](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3695359).

Citations:
[209](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23610374/citedby/)
Fields:

Hem Hematology

Translation:HumansCells

  47. **GRILLEY B** J. Submitting and Conducting a Sponsor-Investigator IND: Lessons Learned...The Hard Way. SoCRA Source. 2012; (72):26-32.

  48. . Drug Information: A Guide for Pharmacists. Investigational Drugs in the Principles and Practice of Drug Information. 2012.

  49. Di Stasi A, Tey SK, Dotti G, Fujita Y, Kennedy-Nasser A, [Martinez C](https://profiles.viictr.org/profile/265827), Straathof K, Liu E, Durett AG, **Grilley B** , [Liu H](https://profiles.viictr.org/profile/265543), Cruz CR, Savoldo B, [Gee AP](https://profiles.viictr.org/profile/268378), Schindler J, [Krance RA](https://profiles.viictr.org/profile/268199), [Heslop HE](https://profiles.viictr.org/profile/269811), Spencer DM, [Rooney CM](https://profiles.viictr.org/profile/268355), [Brenner MK](https://profiles.viictr.org/profile/268200). Inducible apoptosis as a safety switch for adoptive cell therapy. N Engl J Med. 2011 Nov 03; 365(18):1673-83. PMID: [22047558](//www.ncbi.nlm.nih.gov/pubmed/22047558); PMCID: [PMC3236370](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3236370).

Citations:
[654](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22047558/citedby/)
Fields:

Med Medicine (General)

Translation:HumansCellsCTClinical Trials

  50. Savoldo B, [Ramos CA](https://profiles.viictr.org/profile/267038), Liu E, Mims MP, Keating MJ, [Carrum G](https://profiles.viictr.org/profile/269657), [Kamble RT](https://profiles.viictr.org/profile/265557), Bollard CM, [Gee AP](https://profiles.viictr.org/profile/268378), [Mei Z](https://profiles.viictr.org/profile/267093), [Liu H](https://profiles.viictr.org/profile/265543), **Grilley B** , [Rooney CM](https://profiles.viictr.org/profile/268355), [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), Dotti G. CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients. J Clin Invest. 2011 May; 121(5):1822-6. PMID: [21540550](//www.ncbi.nlm.nih.gov/pubmed/21540550); PMCID: [PMC3083795](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3083795).

Citations:
[473](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21540550/citedby/)
Fields:

Med Medicine (General)

Translation:HumansCells

  51. . Regulatory and Ethical Issues in the Treatment of Children. 2007.

  52. **GRILLEY B** J. Data Safety Monitoring: A Practical Guide for Clinical Researchers. NCURA Newsletter. 2006; XXXVIII:6-7.

  53. . A Peer Reviewed Quality Assurance Program at a Clinical Research Site. ACRP Monitor. 2006; 1-5.

  54. . Institutional Review Board: Management and Function. Gene Therapy Oversight. 2006.

  55. **GRILLEY B** J. Drug Information: A Guide for Pharmacists. Investigational Drugs in the Principles and Practice of Drug Information. 2006.

  56. **GRILLEY B** J. Improve Quality with a Trial Monitoring Program. Clinical Trials Administrator. 2005; 3:127-130.

  57. Biagi E, Yvon ES, Brown MP, Lin T, [Mei Z](https://profiles.viictr.org/profile/267093), **Grilley B** , Popek E, [Heslop HE](https://profiles.viictr.org/profile/269811), [Gee AP](https://profiles.viictr.org/profile/268378), [Krance RA](https://profiles.viictr.org/profile/268199), [Popat U](https://profiles.viictr.org/profile/12583693), [Carrum G](https://profiles.viictr.org/profile/269657), [Margolin JF](https://profiles.viictr.org/profile/268091), [Brenner MK](https://profiles.viictr.org/profile/268200), Rousseau RF, Dutour A. Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation. Blood. 2006 Feb 15; 107(4):1332-41. PMID: [16249392](//www.ncbi.nlm.nih.gov/pubmed/16249392); PMCID: [PMC1895421](//www.ncbi.nlm.nih.gov/pmc/articles/PMC1895421).

Citations:
[24](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16249392/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  58. Biagi E, Rousseau R, Yvon E, Schwartz M, Dotti G, Foster A, Havlik-Cooper D, **Grilley B** , [Gee A](https://profiles.viictr.org/profile/268378), Baker K, [Carrum G](https://profiles.viictr.org/profile/269657), Rice L, [Andreeff M](https://profiles.viictr.org/profile/12582880), [Popat U](https://profiles.viictr.org/profile/12583693), [Brenner M](https://profiles.viictr.org/profile/268200). Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemia. Clin Cancer Res. 2005 Oct 01; 11(19 Pt 1):6916-23. PMID: [16203783](//www.ncbi.nlm.nih.gov/pubmed/16203783).

Citations:
[26](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16203783/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  59. **GRILLEY B** J. Data Review Committees Offer Additional Protection. Clinical Trials Administrator. 2005; 3:101-102.

  60. . Study Guide for Institutional Review Board Management and Function. Gene Therapy Oversight. 2005.

  61. **Grilley BJ** , [Gee AP](https://profiles.viictr.org/profile/268378). Gene transfer: regulatory issues and their impact on the clinical investigator and the good manufacturing production facility. Cytotherapy. 2003; 5(3):197-207. PMID: [12850787](//www.ncbi.nlm.nih.gov/pubmed/12850787).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12850787/citedby/) Fields:

Cel Cell BiologyThe Therapeutics

  62. Haight AE, Hirschmann-Jax C, Yvon ES, Rill DR, [Mei Z](https://profiles.viictr.org/profile/267093), Smith SC, Inman S, Cooper K, Alcoser P, **Grilley B** , [Gee A](https://profiles.viictr.org/profile/268378), Popek E, Davidoff A, Bowman LC, [Brenner MK](https://profiles.viictr.org/profile/268200), Strother D, Rousseau RF. Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma. Blood. 2003 Mar 01; 101(5):1718-26. PMID: [12406881](//www.ncbi.nlm.nih.gov/pubmed/12406881).

Citations:
[38](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/12406881/citedby/) Fields:

Hem Hematology

Translation:HumansCellsCTClinical Trials

  63. Kramer MA, **Grilley BJ**. Gaining access to investigational drugs for treatment: an investigational new drug application primer. Int J Pharm Compd. 2002 Jul-Aug; 6(4):271-3. PMID: [23979304](//www.ncbi.nlm.nih.gov/pubmed/23979304).

Citations:  Fields:

Pha Pharmacy

  64. . Study Guide for Institutional Review Board: Management and Function. Gene Therapy Oversight. 2002.

  65. . Institutional Review Board: Management and Function. Gene Therapy Oversight. 2002.

  66. . Drug Information: A Guide for Pharmacists. Investigational Drugs in the Principles and Practice of Drug Information. 2001.

  67. **Grilley BJ** , Aguilar LK, Aguilar-Cordova E. Reporting adverse events in gene therapy studies. BioDrugs. 2000 Sep; 14(3):141-5. PMID: [18034566](//www.ncbi.nlm.nih.gov/pubmed/18034566).

Citations:  Fields:

All Allergy and ImmunologyDru Drug TherapyGen GeneticsThe Therapeutics

  68. Brenner MK, [Heslop H](https://profiles.viictr.org/profile/269811), [Krance R](https://profiles.viictr.org/profile/268199), Horowitz M, Strother D, [Nuchtern J](https://profiles.viictr.org/profile/266271), **Grilley B** , Martingano E, Cooper K. Phase I study of chemokine and cytokine gene-modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma using an adenoviral vector. Hum Gene Ther. 2000 Jul 01; 11(10):1477-88. PMID: [10910144](//www.ncbi.nlm.nih.gov/pubmed/10910144).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10910144/citedby/) Fields:

Gen GeneticsThe Therapeutics

Translation:HumansCellsCTClinical Trials

  69. [Heslop H](https://profiles.viictr.org/profile/269811), [Rooney C](https://profiles.viictr.org/profile/268355), Brenner M, [Krance R](https://profiles.viictr.org/profile/268199), [Carrum G](https://profiles.viictr.org/profile/269657), Gahn B, Bollard C, Khan S, [Gee A](https://profiles.viictr.org/profile/268378), [Popat U](https://profiles.viictr.org/profile/12583693), Gresik M, Przepiorka D, Kuehnle I, **Grilley B**. Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease. Hum Gene Ther. 2000 Jul 01; 11(10):1465-75. PMID: [10910143](//www.ncbi.nlm.nih.gov/pubmed/10910143).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10910143/citedby/) Fields:

Gen GeneticsThe Therapeutics

Translation:HumansCellsCTClinical Trials

  70. Roskrow MA, [Rooney CM](https://profiles.viictr.org/profile/268355), [Heslop HE](https://profiles.viictr.org/profile/269811), Brenner MK, [Krance RA](https://profiles.viictr.org/profile/268199), Gresik MV, [McClain K](https://profiles.viictr.org/profile/266880), Aguilar LK, **Grilley B** , Rob E, [Carrum G](https://profiles.viictr.org/profile/269657). Administration of neomycin resistance gene marked EBV specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive Hodgkin disease. Hum Gene Ther. 1998 May 20; 9(8):1237-50. PMID: [9625264](//www.ncbi.nlm.nih.gov/pubmed/9625264).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9625264/citedby/) Fields:

Gen GeneticsThe Therapeutics

Translation:HumansCellsCTClinical Trials

  71. . Drug Information: A Guide for Pharmacists. Investigational Drugs in the Principles and Practice of Drug Information. 1996.

  72. **Grilley BJ** , Trissel LA, Bluml BM. Design and implementation of an electronic investigational drug accountability system. Am J Hosp Pharm. 1991 Dec; 48(12):2616-8. PMID: [1814202](//www.ncbi.nlm.nih.gov/pubmed/1814202).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1814202/citedby/) Fields:

Hos HospitalsPha Pharmacy

Translation:Humans

  73. Trissel LA, Tramonte SM, **Grilley BJ**. Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection. Am J Hosp Pharm. 1991 May; 48(5):988-92. PMID: [1830190](//www.ncbi.nlm.nih.gov/pubmed/1830190).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1830190/citedby/) Fields:

Hos HospitalsPha Pharmacy

  74. . Fludarabine phosphate: a new agent for lymphoproliferative malignancies. The Cancer Bulletin. 1991; 43:583-584.

This graph shows the total number of publications by year. To see the data as
text, click here.

![Bar chart showing 71 publications over 23 distinct years, with a maximum of
10 publications in
2022](//chart.googleapis.com/chart?chs=595x100&chf=bg,s,ffffff|c,s,ffffff&chxt=x,y&chxl=0:|'94||'96||'98||'00||'02||'04||'06||'08||'10||'12||'14||'16||'18||'20||'22||'24|1:|0|10&cht=bvs&chd=t:0,0,10,0,10,0,30,10,40,10,0,50,40,10,0,0,0,20,20,20,30,30,10,50,20,10,30,20,100,60,80&chdl=Publications&chco=80B1D3&chbh=10)

This graph shows the total number of publications by year. To return to the
graph, click here.

Year| Publications  
---|---  
1996| 1  
1998| 1  
2000| 3  
2001| 1  
2002| 4  
2003| 1  
2005| 5  
2006| 4  
2007| 1  
2011| 2  
2012| 2  
2013| 2  
2014| 3  
2015| 3  
2016| 1  
2017| 5  
2018| 2  
2019| 1  
2020| 3  
2021| 2  
2022| 10  
2023| 6  
2024| 8  
  
This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

Start with: newest oldest Include: line numbers double spacing all authors
publication IDs

GRILLEY's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (227)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

Derived automatically from this person's publications.

  * [T-Lymphocytes](https://profiles.viictr.org/profile/263702)
  * [Immunotherapy, Adoptive](https://profiles.viictr.org/profile/250092)
  * [Receptors, Antigen, T-Cell](https://profiles.viictr.org/profile/244627)
  * [Tissue and Organ Procurement](https://profiles.viictr.org/profile/256624)
  * [Hematopoietic Stem Cell Transplantation](https://profiles.viictr.org/profile/244961)

[Explore](https://profiles.viictr.org/profile/266987/198)

_

Co-Authors (76)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People in Profiles who have published with this person.

  * [HESLOP, HELEN](https://profiles.viictr.org/profile/269811)
  * [BRENNER, MALCOLM](https://profiles.viictr.org/profile/268200)
  * [LULLA, PREMAL](https://profiles.viictr.org/profile/3010220)
  * [GEE, ADRIAN](https://profiles.viictr.org/profile/268378)
  * [RAMOS, CARLOS](https://profiles.viictr.org/profile/267038)

[Explore](https://profiles.viictr.org/profile/266987/345)

_

Similar People (60)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People who share similar concepts with this person.

  * [HESLOP, HELEN](https://profiles.viictr.org/profile/269811)
  * [CHAMPLIN, RICHARD E](https://profiles.viictr.org/profile/12582508)
  * [GOTTSCHALK, STEPHEN](https://profiles.viictr.org/profile/270181)
  * [ROONEY, CLIONA](https://profiles.viictr.org/profile/268355)
  * [BRENNER, MALCOLM](https://profiles.viictr.org/profile/268200)

[Explore](https://profiles.viictr.org/profile/266987/476)

_

Same Department [ ![Expand
Description](https://profiles.viictr.org/Framework/Images/info.png)
](JavaScript:toggleVisibility\('sdDescript'\);)

People who are also in this person's primary department.

  * [CRADDOCK, JOHN](https://profiles.viictr.org/profile/27841637)
  * [KRUEGER, RACHEL](https://profiles.viictr.org/profile/40483019)
  * [OMER, BILAL](https://profiles.viictr.org/profile/3009902)
  * [ROONEY, CLIONA](https://profiles.viictr.org/profile/268355)
  * [SALMAN, ROSEEN](https://profiles.viictr.org/profile/37104181)

[Explore](https://profiles.viictr.org/search/default.aspx?searchtype=people&searchfor=&SearchRequest=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)

_

Physical Neighbors
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People whose addresses are nearby this person.

  * [AHMED, NABIL](https://profiles.viictr.org/profile/268944)
  * [DAVIS, ELIZABETH](https://profiles.viictr.org/profile/269827)
  * [GOTTSCHALK, STEPHEN](https://profiles.viictr.org/profile/270181)
  * [LEEN, ANN](https://profiles.viictr.org/profile/268626)
  * [MARTINEZ, CARIDAD](https://profiles.viictr.org/profile/265827)

_

